BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22621957)

  • 1. Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome.
    Cliffe ST; Bloch DB; Suryani S; Kamsteeg EJ; Avery DT; Palendira U; Church JA; Wainstein BK; Trizzino A; Lefranc G; Akatcherian C; Megarbané A; Gilissen C; Moshous D; Reichenbach J; Misbah S; Salzer U; Abinun M; Ong PY; Stepensky P; Ruga E; Ziegler JB; Wong M; Tangye SG; Lindeman R; Buckley MF; Roscioli T
    J Allergy Clin Immunol; 2012 Sep; 130(3):735-742.e6. PubMed ID: 22621957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic veno-occlusive disease with immunodeficiency (VODI): first reported case in the U.S. and identification of a unique mutation in Sp110.
    Wang T; Ong P; Roscioli T; Cliffe ST; Church JA
    Clin Immunol; 2012 Nov; 145(2):102-7. PubMed ID: 22982295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease.
    Roscioli T; Cliffe ST; Bloch DB; Bell CG; Mullan G; Taylor PJ; Sarris M; Wang J; Donald JA; Kirk EP; Ziegler JB; Salzer U; McDonald GB; Wong M; Lindeman R; Buckley MF
    Nat Genet; 2006 Jun; 38(6):620-2. PubMed ID: 16648851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency.
    Marquardsen FA; Baldin F; Wunderer F; Al-Herz W; Mikhael R; Lefranc G; Baz Z; Rezaee F; Hanna R; Kfir-Erenfeld S; Stepensky P; Meyer B; Jauch A; Bigler MB; Burgener AV; Higgins R; Navarini AA; Church JA; Chou J; Geha R; Notarangelo LD; Hess C; Berger CT; Bloch DB; Recher M
    J Clin Immunol; 2017 Oct; 37(7):707-714. PubMed ID: 28825155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first prenatal diagnosis for veno-occlusive disease and immunodeficiency syndrome, an autosomal recessive condition associated with mutations in SP110.
    Cliffe ST; Wong M; Taylor PJ; Ruga E; Wilcken B; Lindeman R; Buckley MF; Roscioli T
    Prenat Diagn; 2007 Jul; 27(7):674-6. PubMed ID: 17510920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hematopoietic stem cell transplantation in SP110 associated veno-occlusive disease with immunodeficiency syndrome.
    Ganaiem H; Eisenstein EM; Tenenbaum A; Somech R; Simanovsky N; Roscioli T; Weintraub M; Stepensky P
    Pediatr Allergy Immunol; 2013 May; 24(3):250-6. PubMed ID: 23448538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased IL-10 production by EBV-transformed B cells from patients with VODI: implications for the pathogenesis of Crohn disease.
    Bloch DB; Nobre R; Steinbicker AU; Al-Herz W; Notarangelo LD; Recher M
    J Allergy Clin Immunol; 2012 Jun; 129(6):1678-80. PubMed ID: 22341038
    [No Abstract]   [Full Text] [Related]  

  • 8. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation.
    van Zelm MC; Bartol SJ; Driessen GJ; Mascart F; Reisli I; Franco JL; Wolska-Kusnierz B; Kanegane H; Boon L; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Jul; 134(1):135-44. PubMed ID: 24418477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comèl-Netherton syndrome defined as primary immunodeficiency.
    Renner ED; Hartl D; Rylaarsdam S; Young ML; Monaco-Shawver L; Kleiner G; Markert ML; Stiehm ER; Belohradsky BH; Upton MP; Torgerson TR; Orange JS; Ochs HD
    J Allergy Clin Immunol; 2009 Sep; 124(3):536-43. PubMed ID: 19683336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients.
    Meshaal S; El Hawary R; Adel R; Abd Elaziz D; Erfan A; Lotfy S; Hafez M; Hassan M; Johnson M; Rojas-Restrepo J; Gamez-Diaz L; Grimbacher B; Shoman W; Abdelmeguid Y; Boutros J; Galal N; El-Guindy N; Elmarsafy A
    J Clin Immunol; 2020 Aug; 40(6):820-832. PubMed ID: 32506362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels.
    Schmetterer KG; Seidel MG; Körmöczi U; Rottal A; Schwarz K; Matthes-Martin S; Steinberger P; Pickl WF
    Int Arch Allergy Immunol; 2010; 152(4):390-400. PubMed ID: 20197681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique Mutation in SP110 Resulting in Hepatic Veno-Occlusive Disease with Immunodeficiency.
    Hamdoun O; Al Mulla A; Al Zaabi S; Shendi H; Al Ghamdi S; Hertecant J; Al-Shibli A
    Case Rep Pediatr; 2020; 2020():3460631. PubMed ID: 32395362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The defect in humoral immunity in patients with Nijmegen breakage syndrome is explained by defects in peripheral B lymphocyte maturation.
    Piątosa B; van der Burg M; Siewiera K; Pac M; van Dongen JJ; Langerak AW; Chrzanowska KH; Bernatowska E
    Cytometry A; 2012 Oct; 81(10):835-42. PubMed ID: 22851427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
    Saiki O; Tanaka T; Wada Y; Uda H; Inoue A; Katada Y; Izeki M; Iwata M; Nunoi H; Matsuda I
    J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining combined immunodeficiency.
    Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
    J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antibody-deficiency syndrome due to mutations in the CD19 gene.
    van Zelm MC; Reisli I; van der Burg M; Castaño D; van Noesel CJ; van Tol MJ; Woellner C; Grimbacher B; Patiño PJ; van Dongen JJ; Franco JL
    N Engl J Med; 2006 May; 354(18):1901-12. PubMed ID: 16672701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
    Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
    Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis.
    Moshous D; Pannetier C; Chasseval Rd Rd; Deist Fl Fl; Cavazzana-Calvo M; Romana S; Macintyre E; Canioni D; Brousse N; Fischer A; Casanova JL; Villartay JP
    J Clin Invest; 2003 Feb; 111(3):381-7. PubMed ID: 12569164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-content cytometry and transcriptomic biomarker profiling of human B-cell activation.
    Hennig C; Ilginus C; Boztug K; Skokowa J; Marodi L; Szaflarska A; Sass M; Pignata C; Kilic SS; Caragol I; Baumann U; Klein C; Welte K; Hansen G
    J Allergy Clin Immunol; 2014 Jan; 133(1):172-80.e1-10. PubMed ID: 24012209
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.